article June 10, 2021
FDA leader: ‘stockpiling’ could transform clinical trial system
In the fourth and final article of this Outsourcing Pharma series, Acting FDA Commissioner Janet Woodcock discusses ways to overcome barriers in the clinical research industry, including the integration of research into large health systems to connect clinical research to clinical care. As Javara CEO Jennifer Byrne shared in an earlier article, an integrated approach is critical to building stronger relationships between researchers, doctors, and patients, and Janet Woodcock only furthers this by adding insights on how the different roles across the industry can work together for success. Click the link below to view the full article:
Javara is the leading Integrated Research Organization (IRO) partnering with large healthcare organizations in local communities across the US to integrate clinical research into clinical care. Our access to broad diverse patient populations through their trusted physicians ensures clinical trials are completed with high enrollment and retention for quality data delivery. Javara’s centralized resources and standardized operations provide efficiencies for accelerated study start-up and quality outcomes, so fewer obstacles stand in the way of the product approval process. Our team includes experienced clinical research leaders who have collectively led 10,000+ trials and engaged 200,000+ patients in clinical trials. As pioneers of Clinical Research as a Care Option (CRAACO), Javara is transforming healthcare and changing lives by connecting the right patients to the right trials at the right time. For more information, please visit Javararesearch.com.
Javara Media Contact: